Addressing missing outcome data in meta-analysis (Q30835835)

27 June 2017

1 reference

Addressing missing outcome data in meta-analysis (English)

1 reference

27 June 2017

1 reference

Orestis Efthimiou

3

0 references

Anna Chaimani

object named as

Anna Chaimani

2

0 references

Georgia Salanti

object named as

Georgia Salanti

5

0 references

author name string

Dimitris Mavridis

1

1 reference

27 June 2017

Stefan Leucht

4

1 reference

27 June 2017

language of work or name

English

0 references

publication date

9 July 2014

1 reference

Evidence-Based Mental Health

27 June 2017

published in

1 reference

27 June 2017

volume

17

1 reference

27 June 2017

issue

3

1 reference

27 June 2017

page(s)

85-89

1 reference

Dropout rates in randomised antipsychotic drug trials

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

The prevention and treatment of missing data in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Intention-to-treat analysis: implications for quantitative and qualitative research

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Allowing for uncertainty due to missing data in meta-analysis--part 2: hierarchical models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Is the superior efficacy of new generation antipsychotics an artifact of LOCF?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Uncertainty method improved on best-worst case analysis in a binary meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Imputation methods for missing outcome data in meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Missing data: our view of the state of the art

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

Special Topics in Statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2014-101900

21 January 2018

Identifiers

DOI

10.1136/EB-2014-101900

1 reference

release_gyx4ybornva7ha7aniaxwo3mfe

27 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gyx4ybornva7ha7aniaxwo3mfe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference